HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mortality and risk factors for invasive fungal infections after the implementation of a fluconazole prophylaxis protocol in very low birth weight infants.

AbstractUNLABELLED:
Fungal infections are a common cause of late-onset sepsis in very low birth weight infants and can impact mortality and morbidity. The purpose of this study is to determine the impact of systemic fluconazole prophylaxis in the prevalence of fungemia.
METHODS:
Subjects included 402 very low birth weight premature infants with birth weights between 500 and 1,250 grams admitted to the University Pediatric Hospital NICU over a six year period. The period before and after prophylaxis was retrospectively compared
RESULTS:
There was a marginal decrease in fungemia in the prophylaxis group (2.6% vs. 6.7%, p = 0.0525). Factors associated to fungemia were chorioamnionitis (p = 0.0240), H2-receptor inhibitors use (p = 0.0109), mechanical ventilati (p = 0.0049), prolonged antibiotic t py (p = 0.0015), and parenteral nutriti (p = 0.0048). Infants with fungemia had longer lengths of stay (p = 0.0143) and lower survival (p = 0.002).
CONCLUSION:
Prophylaxis with fluconazole decreases mortality and morbidity in an environment with a high incidence of late onset fungal infections. Early identification and prevention of risk factors must be reinforced.
AuthorsAlessandro M Acosta, Inés García-García, Lourdes García-Fragoso, Gloria Reyes, Juan Rivera, Marta Valcárcel
JournalBoletin de la Asociacion Medica de Puerto Rico (Bol Asoc Med P R) Vol. 105 Issue 4 Pg. 9-13 ( 2013) ISSN: 0004-4849 [Print] Puerto Rico
PMID25154166 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Fluconazole
Topics
  • Antifungal Agents (therapeutic use)
  • Clinical Protocols
  • Female
  • Fluconazole (therapeutic use)
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight
  • Male
  • Mycoses (mortality, prevention & control)
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: